Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the comparative effectiveness of upadacitinib versus corticosteroids as initial therapy for acute severe ulcerative colit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)
  • RINVOQ (Upadacitinib)

Snippet

Sponsor: Yongquan Shi | Conditions: Acute Severe Ulcerative Colitis | Phase 4 | Status: RECRUITING